Article History
Received: 7 December 2018
Accepted: 24 May 2019
First Online: 31 May 2019
Compliance with ethical standards
:
: Cedars-Sinai has a licensing agreement with Salix Pharmaceuticals and Gemelli Biotech. Mark Pimentel is a founder of Gemelli Biotech, has equity in the company, and serves on the board. Ali Rezaie is a founder of Gemelli Biotech and also has equity in the company. Walter Morales is a consultant for Gemelli Biotech. Gillian Barlow has no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.